A diagnostic tool that treats autism like cancer
Increasing evidence suggests a link between autism and autoimmune diseases. Now an Israeli startup is developing a diagnostic tool for autoimmune antibody associated autism.
Increasing evidence suggests a link between autism and autoimmune diseases. Now an Israeli startup is developing a diagnostic tool for autoimmune antibody associated autism.
Scientists have discovered that the immune system can find bacteria residing within cancer cells and use them to provoke an immune reaction against a tumor.
Natural killer cells treatment offers the potential for an effective, safer treatment option than most current immunotherapies.
Immunotherapy profiling, medication tracking, digital farming system among nine Israeli startups winning joint project grants.
Novel immunotherapy extends therapy now used in fighting leukemia,
Israeli researchers say.
Israeli study reveals the reason that some cancer patients don’t respond to immunotherapy.
Injection of synthetic DNA material found to activate brain’s immune cellsand kill invading cancer cells, Israeli researchers say.
New Israeli study finds white blood cells related to allergies and asthma may also be harnessed to destroy cancer cells.
Purified, activated immune cells from a healthy donor are injected into the recipient until the immune system can hunt down cancer cells on its own.
Discovery could allow enhanced activity of the immune system to attack cancer cells, in particular in cases of lung cancer and melanoma.
Researchers at the Technion successfully shrank malignant tumors in mice by manipulating the brain’s reward system.
Expertise in data science has pushed Israel to the forefront in devising technologies for predicting the best course of treatment for each patient.
Israeli scientist Rony Dahan thinks he knows why immunotherapy hasn’t reached its full potential, and he aims to do something about that.
Personalized cancer treatment maker, Kite Pharma, is led by Israeli-American oncologist and based on research from Israel’s Weizmann Institute.
Ethosia report shows 33 companies raised $869.3 million in investments while five startups exited at over $800 million from January-March 2016.